Prophylactic Medication for the Prevention of Endoscopic Recurrence in Crohn's Disease: a Prospective Study Based on Clinical Risk Stratification.

"Conflict of Interest Jeanine H. C. Arkenbosch, Evelien M. J. Beelen, Mariëlle Romberg-Camps, Sander van der Marel, P. W. Jeroen Maljaars, Sita Jansen, Carmen S. Horjus, Laurents P. S. Stassen, Bindia J. H. Jharap, Alfred Janssen, Nicole S. Erler, Michail Doukas, Ariadne H. A. G. Ooms, Gursah Kats-Ugurlu: none. Gerard Dijkstra has received a grant from Royal DSM and speaker fees from Abbvie, Janssen-Cilag, Takeda and Pfizer, all outside the submitted work. Marjolijn Duijvestein has received advisory fees from Echo Pharma, Alimentiv [formerly Robarts Clinical Trials]; unrestricted grants from Pfizer; speaker fees from Janssen, Merck & Co., Inc., Pfizer, Takeda, Tillotts Pharma, Galapagos, and BMS; and received nonfinancial support from Dr. Falk Pharma, all outside the submitted work. Frank Hoentjen has served on advisory boards or as a speaker for Abbvie, Janssen-Cilag, MSD, Takeda, Celltrion, Teva, Sandoz, and Dr Falk; received funding [Grants/Honoraria] from Dr Falk, Janssen-Cilag, Abbvie, and Takeda; and received consulting fees from Celgene, Janssen-Cilag, all outside the submitted work. Nanne K. H. de Boer has served as a speaker for AbbVie and MSD; served as a consultant and principal investigator for TEVA Pharma BV and Takeda; and received [unrestricted] research grant support from Dr. Falk, TEVA Pharma BV, MLDS and Takeda, all outside the submitted work. Rachel West has served on the advisory board and as invited speaker for Janssen, Pfizer, Takeda, and Galapagos, outside the submitted work. Fiona D. M. van Schaik has served on the advisory board for Falk, Takeda, and Galapagos, outside the submitted work. Oddeke van Ruler has served as an invited speaker for Janssen-Cilag; and has received non-financial support from Takeda, outside the submitted work. Marijn Visschedijk has served on the advisory board for Janssen-Cilag; and received speaker fees from Takeda, outside the submitted work. C. Janneke van der Woude received grants and/or fees for advisory boards and presentations from Pfizer, Abbvie, Celltrion, Falk Benelux, Takeda, Janssen, and Ferring, outside the submitted work. Annemarie C. de Vries has served on the advisory boards for Takeda, Janssen, Bristol Myers Squibb, Abbvie, Pfizer, and Galapagos; and received unrestricted research grants from Takeda, Janssen, and Pfizer, outside the submitted work."

"Funding None."